In Vitro Susceptibility of Clinical Staphylococcus aureus Small-Colony Variants to β-Lactam and Non-β-Lactam Antibiotics

Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02532-17. doi: 10.1128/AAC.02532-17. Print 2018 Apr.

Abstract

The Staphylococcus aureus small-colony variant (SCV) phenotype has been associated with relapsing and antibiotic-refractory infections. However, little is known about the activities of antibiotics on clinical SCVs. Here, we demonstrated that SCVs without detectable auxotrophies were at least as susceptible to most β-lactam and non-β-lactam antibiotics in vitro as their corresponding clonally identical strains with a normal phenotype. After prolonged incubation, a regrowth phenomenon has been observed in gradient diffusion inhibition zones irrespective of the strains' phenotype.

Keywords: Staphylococcus aureus; aminoglycosides; antibiotic resistance; daptomycin; lincosamides; linezolid; resistance; small-colony variants; susceptibility; trimethoprim; β-lactam antibiotics.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Daptomycin / pharmacology
  • Lincosamides / pharmacology
  • Linezolid / pharmacology
  • Microbial Sensitivity Tests
  • Staphylococcus aureus / drug effects*
  • Trimethoprim / pharmacology
  • beta-Lactams / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Lincosamides
  • beta-Lactams
  • Trimethoprim
  • Linezolid
  • Daptomycin